Claim(permalink)
In November 2020, the Canadian government approved the use of psilocybin therapy, which uses the hallucinogenic chemical compound found in psychedelic mushrooms, to ease anxiety and depression associated with a terminal diagnosis.
Factors
veracity
Political Leaning
Sentiment
Date published
2020-11-18
Entities
MarsConsciousnessSubstance dependencePsilocybin therapyHer Story (video game)Mona VanderwaalCode of Federal RegulationsOpioid use disorderPsychotherapyPalliative careBuddy HollyPsilocybin mushroomFederal government of the United StatesControlled Substances ActLysergic acid diethylamideClinical trialMental disorderAnxietyMedicationCloudMajor depressive disorderOregonCityCanadaCancerPsilocybinObsessive–compulsive disorderTreatment-resistant depression
